Harvard Bioscience's total assets for Q1 2025 were $79.80M, a decrease of -36.99% from the previous quarter. HBIO total liabilities were $64.97M for the fiscal quarter, a 2.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.